Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

Abstract

After failure to achieve SVR with TVR-based treatment, resistant variants are observed in most patients. However, presumably due to the lower fitness of those variants, they tend to be replaced with wild-type virus over time.